Real-world evidence for meningococcal B vaccines and how to have MenB conversations in general practice

Description

In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ralph Audehm & Prof Jeremy Grummet

A/Prof Ralph Audehm & Prof Jeremy Grummet

New Prostate Cancer Screening Guidelines – Case-Based Explanation for GP

Dr Katherine Spira

Dr Katherine Spira

Acute Migraine Management

A/Prof Gary Kilov AM

A/Prof Gary Kilov AM

Continuous Glucose Monitoring Update – Why it will Soon Become Standard Care

Dr Aviv Pudipeddi & Dr David Lim

Dr Aviv Pudipeddi & Dr David Lim

Faecal Calprotectin – A Practical Guide to the Test and the New Item Number

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Peter Richmond

expert

Prof Peter Richmond

Consultant Paediatric Immunologist & Paediatrician, Perth Children’s Hospital. Head, Department of Immunology, Child & Adolescent Health Service WA. Director, Vaccine Trials Group, Wesfarmers Centre of Vaccines & Infectious Diseases, The Kids Research Institute Australia.

Date published: 21 June 2022